Australian entrepreneur launches Gamgee, personalized mRNA cancer vaccine startup for dogs

Paul Conyngham launched Gamgee, a startup developing personalized mRNA cancer vaccines for dogs using AI and genetic analysis. The company was inspired by Conyngham's use of ChatGPT, Grok, and other AI tools to create a custom vaccine for his dog Rosie, who had cancer. While initially focused on canines, Gamgee plans to expand its AI-powered treatment approach to other species, including humans, leveraging machine learning to design personalized therapies based on genetic profiles.